(Total Views: 360)
Posted On: 03/09/2021 1:41:28 PM
Post# of 153904
Has someone an explanation for this?
"...This inadvertent move inordinately reduced the overall mortality of the placebo arm of the trial. Instead of facing a historical placebo mortality rate of 35% the company was more likely facing a 23% mortality rate. The deaths not reported in the placebo arm dramatically shifted the scales, and in spite of the overwhelming clinical twist of fate the clinical trial still met its endpoint!..."
Is this mortality rate for the placebo group (SOC) not exceptionally low?
"...This inadvertent move inordinately reduced the overall mortality of the placebo arm of the trial. Instead of facing a historical placebo mortality rate of 35% the company was more likely facing a 23% mortality rate. The deaths not reported in the placebo arm dramatically shifted the scales, and in spite of the overwhelming clinical twist of fate the clinical trial still met its endpoint!..."
Is this mortality rate for the placebo group (SOC) not exceptionally low?
(1)
(0)
